Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/15/1459   
Active ingredient: Enoxacin
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: Dr Regenold GmbH
Zöllinplatz 4, 79410 Badenweiler, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/03/2015 Orphan designation EMA/OD/283/14 (2015)2028 of 19/03/2015
20/10/2015 Transfer of orphan designation EMA/OD/283/14/T/01 (2015)7312 of 16/10/2015
7/07/2017 Change of name and/or address of sponsor